Advertisement
037| Volume 26, ISSUE 10, SUPPLEMENT , S16, October 2020

Lymphocytopenia During Hospitalization for Acute Heart Failure and Its Relationship with Portal Congestion and Right Ventricular Function

      This paper is only available as a PDF. To read, Please Download here.

      Background

      Acute heart failure (AHF) is a heterogeneous syndrome that comprises the activation of multiple counter-regulatory processes including the immune and inflammatory pathways, which worsen the prognosis. Recent data have provided novel insights into the role of the immune and inflammatory systems in the pathogenesis of heart failure (HF), and low lymphocyte count has been proposed as an easily obtained marker of systemic inflammation that has shown a significant association with poor outcomes in this setting. Although the specific pathophysiological pathway underlying the occurrence of lymphocytopenia in HF remain incompletely understood, portal congestion has been involved into impaired leukocyte distribution and altered lymphocyte behavior. However, the associations between lymphocytopenia and ultrasound surrogates for portal congestion have never been reported in AHF. In the current study, we aimed to: characterize the clinical and biochemical variables associated with a low lymphocyte count on admission and at discharge in patients with AHF; assess the potential associations between lymphocyte count and ultrasound surrogates for portal congestion; and explore the relationships between lymphocyte count at discharge and long-term outcomes in AHF.

      Methods

      Clinical, biological and ultrasound assessments were prospectively obtained at the time of hospital admission and at discharge, after decongestive therapy. Patients were compared according to tertiles of absolute lymphocyte count at baseline (very low,<0.87; low,0.87-1.2; normal,>1.2 × 109/L). Right ventricular (RV) function was assessed using tricuspid annular plan systolic excursion (TAPSE). Doppler-derived portal vein pulsatility index (PVPI) was used as a surrogate for portal congestion.

      Results

      103 patients with AHF were prospectively assessed. At baseline, mean absolute lymphocyte count was 1.1 ± 0.6 × 109/L, and 69% of patients had a lymphocyte count below local normal range (1.3 to 4.5 × 109/L). Patients with baseline very low lymphocyte count were older, had more advanced disease and higher PVPI when compared with those in the higher tertiles (all p<0.05). Very low lymphocyte count at baseline was associated with age (OR 1.098), PVPI (OR 1.026) and TAPSE (OR 0.865, all p<0.05). PVPI remained the only determinant of lymphocytopenia at the time of discharge (OR 1.033, p<0.05). In a Cox model, lymphocytopenia at discharge was significantly associated with all-cause of mortality (HR 4.796, p<0.05) after adjusting for age, sex, left ventricular ejection fraction and hemoglobin.

      Conclusions

      Low lymphocyte count in patients hospitalized for AHF is strongly associated with RV dysfunction and ultrasound markers of portal congestion. Whether this association supports the role of portal congestion as a pathophysiological mechanism directly involved in lymphocytopenia in AHF, or whether these two features only reflect a more advanced disease remains to be determined.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect